摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-acetyl-3-(2,4,5-trimethoxy-3-methylphenyl)methyl-2,5-piperazinedione | 113296-72-3

中文名称
——
中文别名
——
英文名称
1-acetyl-3-(2,4,5-trimethoxy-3-methylphenyl)methyl-2,5-piperazinedione
英文别名
1-acetyl-3-(2,4,5-trimethoxy-3-methylphenylmethyl)-2,5-piperazinedione;1-Acetyl-3-[(2,4,5-trimethoxy-3-methylphenyl)methyl]piperazine-2,5-dione
1-acetyl-3-(2,4,5-trimethoxy-3-methylphenyl)methyl-2,5-piperazinedione化学式
CAS
113296-72-3
化学式
C17H22N2O6
mdl
——
分子量
350.371
InChiKey
PJVJBMMXJRREAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    116-118 °C
  • 沸点:
    583.6±50.0 °C(Predicted)
  • 密度:
    1.232±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    94.2
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Pictet Spengler-type reactions in 3-arylmethylpiperazine-2,5-diones. Synthesis of pyrazinotetrahydroisoquinolines
    作者:Juan Francisco González、Elena de la Cuesta、Carmen Avendaño
    DOI:10.1016/j.tet.2004.05.073
    日期:2004.7
    of aldehydes and acetals as N-alkylating agents of 1-acetyl-3-arylmethylpiperazine-2,5-diones and the subsequent cyclization of the N-alkylated products was studied. Use of paraformaldehyde in different reaction conditions gave 6-unsubstituted 3,6,11,11a-tetrahydro-2H-pyrazino[1,2-b]isoquinoline-1,4-diones and, in some cases, benzo[f]pyrazino[1,2-c]1,3-oxazepine-1,4-diones. Succesful reactions with
    研究了醛和缩醛作为1-乙酰基-3-芳基甲基哌嗪-2,5-二酮的N-烷基化剂的行为以及随后N-烷基化产物的环化。在不同的反应条件下使用低聚甲醛得到6-未取代的3,6,11,11a-四氢-2 H-吡嗪并[1,2 - b ]异喹啉-1,4-二酮,在某些情况下还会得到苯并[ f ]吡嗪并[1,2 - c ] 1,3-氧杂氮杂-1,4-二酮。与苯甲醛的成功反应需要首先活化内酰胺功能,并用醛二甲基乙缩醛催化N-烷基化。孤立的O,N将如此获得的酰胺基乙缩醛进行非对映选择性的Pictet Spengler型反应,该反应与在几个环活化度的芳烃噻吩一起产生6-苯基吡嗪异喹啉二酮和相应的噻吩类似物。
  • Synthesis of phthalascidin analogs
    作者:J. Francisco González、Loreto Salazar、Elena de la Cuesta、Carmen Avendaño
    DOI:10.1016/j.tet.2005.05.068
    日期:2005.8
    We report a new approach to obtain phthalascidin analogs. 6-Phthalimidomethylpyrazino[1,2-b]isoquinoline-1,4-dione (5a) was obtained in a one-pot N-alkylation/cyclization of the corresponding 1-acetyl-3-arylmethyl-2,5-piperazinedione with N-phthalylacetaldehyde dimethyl acetal. Chemoselective reduction of the C(1)-carbonyl group in the 3-arylmethyl-11,11a-dehydroderivative 9a was followed by cyclization
    我们报告了一种获得邻苯二酚类似物的新方法。6- Phthalimidomethylpyrazino [1,2 b ]异喹啉-1,4-二酮(5A)在一锅得到Ñ烷基化相应的1-乙酰基-3-芳甲基-2,5-哌嗪二酮与/环化Ñ -邻苯二甲酰乙醛二甲基乙缩醛。对3-芳基甲基-11,11a-脱氢衍生物9a中的C(1)-羰基进行化学选择性还原,然后将酰基中间体中间体环化,得到6,15-亚基-7-氧代-14,14a-脱氢异喹啉[3,2 - b ] 3-苯扎佐星11a。或者,八环化合物13a 通过对C(1)-羰基和一个邻苯二甲酰亚胺羰基进行了还原的前体进行新型双环化反应,得到了α-烯烃。
  • Chemistry of Renieramycins. Part 14: Total Synthesis of Renieramycin I and Practical Synthesis of Cribrostatin 4 (Renieramycin H)
    作者:Masashi Yokoya、Keiichiro Kobayashi、Mitsuhiro Sato、Naoki Saito
    DOI:10.3390/md13084915
    日期:——
    The first total synthesis of (±)-renieramycin I, which was isolated from the Indian bright blue sponge Haliclona cribricutis, is described. The key step is the selenium oxide oxidation of pentacyclic bis-p-quinone derivative (3) stereo- and regioselectively. We also report a large-scale synthesis of cribrostatin 4 (renieramycin H) via the C3-C4 double bond formation in an early stage based on the Avendaño's
    描述了从印度明亮的蓝色海绵嗜盐菌中分离出的(±)-肾上腺素I的第一个全合成。关键步骤是对五环双-对醌衍生物(3)进行立体选择性和区域选择性氧化氧化。我们还报告了基于Avendaño方案在早期阶段通过C3-C4双键形成大规模合成cribrostatin 4(renieramycin H)的方法,该方法是从现成的1-乙酰-3-(3-甲基-2,4) 18步制备1,5-三甲基苯基)甲基-哌嗪-2,5-二酮(8)(总产率8.3%)。该合成提供了明确的证据来支持雷尼霉素I的原始结构。
  • Pyrazino[1,2-b]isoquinolines: Synthesis and study of their cytostatic and cytotoxic properties
    作者:Irene Ortín、Juan Francisco González、Elena de la Cuesta、Cristina Manguan-García、Rosario Perona、Carmen Avendaño
    DOI:10.1016/j.bmc.2008.07.083
    日期:2008.10
    The in vitro antitumor potential of novel pyrazino[1,2-b]-isoquinoline-4-ones that contain a half portion of significant natural products was explored in three cancer cell lines: MDA-MB 231 human breast carcinoma, A-549 human lung carcinoma, and HT-29 human colon carcinoma. In general, these compounds show mid to low mu M GI(50)s, but LC(50)s over 100 mu M with the exceptions of compounds 3b and 31 that are moderately toxic in all cell lines, while compound 4a is highly toxic and selective for HT-29 cells with LC50 values in the high nanomolar range. Experiments directed to elucidate possible mechanisms of action with compounds 3a, 29, and 31 showed that compound 3a is able to efficiently induce apoptosis triggered directly from the G2/M phase of cell cycle, while compounds 29 and 31 are potentially cytostatic agents that induce the G1/S arrest of cell cycle. All three compounds do not act through DNA damage, since they do not activate this signaling at the level of sensors, transducers, and executers. Furthermore, the apoptosis induction of 3a is not mediated by activation of pro-apoptotic kinases JNK and p38 or by activation of AKT. (C) 2008 Elsevier Ltd. All rights reserved.
  • Synthetic Studies on Saframycin Anibiotics: An Improved Synthesis of Tricyclic Lactam Intermediate and Construction of the Core Ring System of Saframycin A
    作者:Naoki Saito、Shinya Kimura、Shintaro Kawai、Masayuki Azuma、Yu-ichi Koizumi、Masashi Yokoya、Yoshifumi Umehara
    DOI:10.3987/com-14-s(k)24
    日期:——
    An improved synthesis of the tricyclic lactam intermediate of saframycin antibiotics and the construction of the core ring system having a cyano group at C-21 position were presented.(1) The stereochemistry of several key intermediates was determined by X-ray crystallographic analysis.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸